Patents Examined by John W. Rolling, Jr.
  • Patent number: 4708952
    Abstract: A composition adapted to prolong the residence time of sulfa and cinchona alkaloid drugs in the circulating plasma of mammals including humans comprising hexanoic acid, potassium hydrogen tartrate, tannic acid, pectin and riboflavin, with the further presence of glutamic acid in the case of sulfa drugs and L-tyrosine in the case of the cinchona alkaloids.
    Type: Grant
    Filed: March 31, 1986
    Date of Patent: November 24, 1987
    Inventor: Aida Salatinjants